Citations

Clear

38 citation(s) found for "Smith, Ryan".

Fat-Free Mass Index in Sport: Normative Profiles and Applications for Collegiate Athletes
Jones, Margaret T. , Fields, Jennifer B. , Magee, Meghan K., Luedke, Joel, Jagim, Andrew R. , Harty, Patrick S. , Smith‐Ryan, Abbie E. , Kerksick, Chad M.

Mayo Clinic

Journal of Strength & Conditioning Research | July 29, 2024 | Volume: 38 | Issue: 9 | Pages: 1687-1693

10.1519/jsc.0000000000004864 | PMID 39074219 Get It

Abstract Jagim, AR, Harty, PS, Jones, MT, Fields, JB, Magee, M, Smith-Ryan, AE, Luedke, J, and Kerksick, CM. Fat-free mass index in sport: normative profiles and applications for collegiate athletes. J Strength Cond Res 38(9): 1687–1693, 2024—Recent concerns have been raised regarding the ethical considerations of conducting body composition assessments in sports. Specific apprehensions pertain to the inappropriate use of percent body fat and the limited application of the results to performance and recovery. Fat-free mass index (FFMI), a height-adjusted assessment of FFM, can serve as an alternative body composition metric to focus on in sports. Fat-free mass index provides valuable context regarding an optimal amount of FFM, accounting for skeletal frame and height while helping to qualify an athlete's FFM as low, moderate, or high. This review posits that shifting the focus of body composition measures to FFM can support more ideal targets across athletic seasons, careers, and the return to play after injury. In addition, a FFM focus may help change the perception of body composition assessment and how athletes perceive their current body because of the increased focus on the FFM compartment and the goal of maximizing tissue accrual, rather than focusing on fat loss. Fat-free mass index is calculated by dividing FFM (kg) by height (m 2 ) and can serve to normalize FFM, relative to height, and enable comparisons across athletes, sport types, and sex. Previous research has identified differences in FFMI across sex and among sport categories. Still, there is a need for more published data to develop optimal ranges for FFMI across sex, sports, and positions. As more data become available, FFMI has the potential to provide normative guidelines for optimal FFM development, performance, and injury risk reduction. The purpose of the current review was to summarize FFMI values across collegiate sport categories and competitive status to provide normative profiles, according to sex and sport type.
Stripping versus ligation of vas deferens in microscopic denervation of spermatic cord in men with chronic orchialgia: A multicenter study
El‐Achkar, Adnan , Hammad, Muhammed , Barham, David , Service, C Austin, Hsieh, Tung- Chin, Mills, Jesse N. , Ziegelmann, Matthew , Smith, Ryan P. , Bernie, Helen L. , Egert, Melissa , Gross, Kelli, Pastuszak, Alex, Hotaling, James M. , Yafi, Faysal A. , Hammad, Muhammed A M , Patel, Darshan P. , Kianian, Reza , Eleswarapu, Sriram Venkata , Bryk, Darren J. , Raheem, Omer A. , Fendereski, Kiarad

Mayo Clinic

Andrology | April 19, 2024 | Volume: 13 | Issue: 2 | Pages: 268-274

10.1111/andr.13650 | PMID 38639020 Get It

AbstractBackgroundMicrodenervation of the spermatic cord (MSCD) is an effective treatment modality for men with intractable scrotal content pain. For patients not interested in preserving fertility, some centers advocate ligation of the vas during denervation, while others prefer stripping of the vas deferens to preserve the vasal artery, hence preserving vasculature to the testis and possibly decreasing post‐operative congestion pain.ObjectiveTo compare outcomes of patients with chronic orchialgia, who underwent MSCD by either stripping or ligating the vas deferens.Materials and methodsA retrospective chart review of 85 patients who underwent MSCD from 2017–2023 was performed. Patients’ demographics including history of prior surgical procedures were recorded. Response to surgery was evaluated as either complete resolution of pain, partial resolution of pain, or no improvement in pain.ResultsEighty‐five patients underwent MSCD with a median (interquartile range, IQR) age of 36 (25.5–46.5) years and median duration of pain of 16 (6–31) months. Thirty‐seven patients underwent stripping of vas, while 48 underwent ligation of vas during MSCD. Median follow up was 12 months. Twenty‐one (43.5%) patients had prior inguinal scrotal surgery in the ligation group compared to 5 (13.5%) in the stripping group, p = 0.003. The etiology of pain was similar between the groups. The response to MSCD between the two groups was similar, 67.6% of patients who underwent stripping had complete resolution of pain versus 66.7% of those who had ligation (p = 0.968), with similar rates of post‐operative complications (p‐value = 0.132).ConclusionsIn men with intractable chronic scrotal content pain with no interest in preserving fertility, ligation, or stripping of the vas deferens yields similar outcomes with regard to pain resolution. Both techniques are safe with no reports of any testicular atrophy.
(130) Multicenter Study Comparing Stripping vs Ligation of Vas Deferens During Microscopic Denervation of Spermatic Cord in Men with Chronic Orchialgia Across the US
Hammad, Muhammed , El‐Achkar, Adnan , Barham, David , Ziegelmann, Matthew , Smith, Ryan P. , Bernie, Helen L. , Raheem, O., Hotaling, James M. , Yafi, Faysal A. , Hammad, Muhammed A M , Hsieh, M, Mills, James L. , Raheem, O, Fendereski, Kiarad

Mayo Clinic

The Journal of Sexual Medicine | March 5, 2024 | Volume: 21 | Issue: Supplement_2 | Pages: No page available

10.1093/jsxmed/qdae002.118 Get It

Abstract Introduction Microdenervation of the spermatic cord (MSCD) is an effective treatment modality for men with intractable scrotal content pain. For patients not interested in preserving fertility, some centers advocate ligation of the vas during denervation while others perfer stripping of the Vas deferens to preserve the vasal artery, hence preserving vasculature to testis and possibly decreasing post operative congestion pain. Objective This multicenter study analyzes outcomes of patients that underwent MSCD by either stripping or ligating the vas deferens. Methods A retrospective chart review of 85 patients who underwent MSCD from 2020–2023 was performed. Patients’ demographics including history of prior surgical procedures was recorded. Response to surgery was evaluated as either complete resolution of pain, partial resolution of pain or no improvement in pain. Results 85 patients underwent MSCD with a median (IQR) age of 36 (25.5–46.5) years and median duration of pain of 16 months. 37 patients underwent stripping of vas while 48 underwent ligation of vas during MSCD. Median follow up was 12 months. 21(43.5%) patients had prior inguinal scrotal surgery in ligation group compared to 5 (13.5%) in the stripping group p=0.003. The etiology of pain was similar between the groups. The response to MSCD between the 2 groups was similar (p=0.968), with similar post op complications (Table 1). Conclusions In men with intractable chronic scrotal content with no interest in preserving fertility, ligation or stripping of the vas deferens yields similar outcomes with regards to pain resolution. Both techniques are safe with no reports of any testicular atrophy. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Advisory board and speaker for Coloplast; consultant for Cynosure; advisory board and speaker for Halozyme; intellectual property with Masimo; advisory board for Promescent; consultant for Sprout; advisory board for Xialla.
Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus
Smith, Ryan A. , Desai, Aakash , Barnes, Edward L. , Hayney, Mary S. , Kochhar, Gursimran , Farraye, Francis A. , Caldera, Freddy , Hayney, Mary , Farraye, Francis A , Caldera, Freddy , Barnes, Edward L , Desai, Aakash , Hashash, Jana G.

Mayo Clinic

American Journal of Gastroenterology | February 6, 2024 | Volume: 119 | Issue: 8 | Pages: 1545-1554

10.14309/ajg.0000000000002682 | PMID 38318981 Get It

INTRODUCTION: Patients with inflammatory bowel disease (IBD) are at increased risk of developing respiratory infections. Respiratory syncytial virus (RSV) is a common respiratory virus with adverse outcomes in older adults. This study aimed to determine whether patients with IBD are at increased risk of a serious infection due to RSV. METHODS: We conducted a retrospective study using the multi-institutional research network TriNetX to assess the risk of hospitalization in a cohort of patients with IBD compared with that in a non-IBD control cohort with RSV infection from January 1, 2007, to February 27, 2023. One-to-one (1:1) propensity score matching was performed for demographic variables and RSV risk factors between the 2 cohorts. Risk was expressed as adjusted odds ratio (aOR) with 95% confidence interval (CI). RESULTS: There were 794 patients in the IBD-RSV cohort and 93,074 patients in the non–IBD-RSV cohort. The mean age of the IBD-RSV cohort was 55.6 ± 20 years, 59% were female, 80% were White, and 56.9% had Crohn's disease. The IBD-RSV cohort was at an increased risk of hospitalization (aOR 1.30, 95% CI 1.06–1.59). There was no difference in the risk (aOR 0.83, 95% CI 0.58–1.19) of a composite outcome of hospitalization-related complications between the 2 cohorts. Recent systemic corticosteroid use (<3 months) was associated with an increased risk of hospitalization (aOR 1.86, 95% CI 1.30–2.59) in the IBD-RSV cohort. DISCUSSION: We found that adult patients with IBD and RSV infection are at an increased risk of hospitalization and may benefit from the new RSV vaccine recommended for adults aged 60 years and older.
(079) Stripping vs Ligation of Vas Deferens in Microscopic Denervation of Spermatic Cord in Men with Chronic Orchialgia: A Multicenter Study
El‐Achkar, Adnan , Hammad, Mustafa , Barham, David , Hsieh, Michael H. , Ziegelmann, Matthew , Smith, Ryan P. , Bernie, Helen L. , Raheem, O., Hotaling, James M. , Yafi, Faysal A. , Hammad, Muhammed , Hammad, Muhammed A M , Hammad, M, Mills, James L. , Raheem, O, Fendereski, Kiarad

Mayo Clinic

The Journal of Sexual Medicine | February 6, 2024 | Volume: 21 | Issue: Supplement_1 | Pages: No page available

10.1093/jsxmed/qdae001.075 Get It

Abstract Introduction Microdenervation of the spermatic cord (MSCD) is an effective treatment modality for men with intractable scrotal content pain. For patients not interested in preserving fertility, some centers advocate ligation of the vas during denervation while others perfer stripping of the Vas deferens to preserve the vasal artery, hence preserving vasculature to testis and possibly decreasing post operative congestion pain. Objective This multicenter study analyzes outcomes of patients that underwent MSCD by either stripping or ligating the vas deferens Methods A retrospective chart review of 85 patients who underwent MSCD from 2020-2023 was performed. Patients’ demographics including history of prior surgical procedures was recorded. Response to surgery was evaluated as either complete resolution of pain, partial resolution of pain or no improvement in pain. Results 85 patients underwent MSCD with a median (IQR) age of 36 (25.5-46.5) years and median duration of pain of 16 months. 37 patients underwent stripping of vas while 48 underwent ligation of vas during MSCD. Median follow up was 12 months. 21(43.5%) patients had prior inguinal scrotal surgery in ligation group compared to 5 (13.5%) in the stripping group p=0.003. The etiology of pain was similar between the groups. The response to MSCD between the 2 groups was similar (p=0.968), with similar post op complications (Table 1). Conclusions In men with intractable chronic scrotal content with no interest in preserving fertility, ligation or stripping of the vas deferens yields similar outcomes with regards to pain resolution. Both techniques are safe with no reports of any testicular atrophy. Disclosure No.
Practice Readiness? Trends in Chief Resident Year Training Experience Across 13 Residency Programs
Corey, Zachary , Lehman, Erik , Lemack, Gary E. , Clifton, Marisa , Atiemo, Humphrey , Sorensen, Mathew D., Smith, Ryan P. , Buckley, Jill C. , Thompson, Houston, Badalato, Gina M., Wallen, Eric, Klausner, Adam P. , Mehta, Akanksha , Lee, Richard S. , Breyer, Benjamin N. , Raman, Jay D.

Mayo Clinic

Urology Practice | December 29, 2023 | Volume: 11 | Issue: 2 | Pages: 430-438

10.1097/upj.0000000000000494 | PMID 38156717 Get It

Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel Disease
Beniwal‐Patel, Poonam , Waclawik, Gabrielle, Browning, Keely, Urmat, Aijan, Schell, Trevor , Smith, Ryan C. , Huerta, Antonio, Hipp, Lauren E. , Davé, Sonya , Shah, Neemit , Dillon, Kayla E, Reiter-Schreurs, Katelyn, Russ, Rachel K., Mailig, Miguel, Osman, Fauzia , Weiss, Jennifer , Caldera, Freddy , Caldera, Freddy , Schell, Trevor L , Huerta, Antonio, Dillon, Kayla , Farraye, Francis A. , Hayney, Mary S.

Mayo Clinic

Crohn's & Colitis 360 | December 15, 2023 | Volume: 5 | Issue: 4 | Pages: No page available

10.1093/crocol/otad078 | PMID 38130948 Get It

Abstract Background and Aims Racial and ethnic disparities exist in the treatment of IBD. These disparities exist in adult vaccine uptake among the general population and may extend to patients with IBD. The primary aim of this study was to determine whether racial, ethnic, or geographic disparities existed in influenza vaccine uptake among patients with IBD. Methods We performed a multicenter, retrospective cohort study evaluating adult vaccine uptake among patients with IBD seen at two tertiary referral centers between September 2019 and February 2020. The primary outcome was to determine if racial/ethnic and geographic disparities existed in influenza vaccine uptake for the two prior seasons. Our secondary outcomes were to determine if disparities existed for pneumococcal, zoster, or hepatitis B vaccines. Results Among the 2453 patients who met the inclusion criteria, most identified as non-Hispanic White (89.9%), were on immunosuppressive therapy (74.5%), and received the influenza vaccine in both seasons (56.0%). Older age (prevalence ratio (PR) 0.98; 95% confidence interval (95%CI) 0.98-0.99; P &lt; .001) and non-Hispanic White patients (PR 0.76, 95%CI 0.59–0.98, P &lt; 0.03) were significantly more likely to be immunized. Black patients (PR 1.37; 95%CI 1.18–1.59; P &lt; .001) and those living in underserved geographic areas (PR 1.35; 95%CI 1.17–1.56; P &lt; 0.001) were less likely to be immunized. Racial/ethnic and geographic disparities were identified for pneumococcal, zoster, and hepatitis B vaccine uptake. Conclusions Racial and ethnic vaccination uptake disparities exist among patients with IBD; patients from medically underserved areas are also vulnerable to these disparities Studies identifying patient, provider, and system-level opportunities to address these disparities are needed.
Sensitivity of MRI in Patients with New Onset Seizures who have Normal CT Imaging and Neurologic Examinations (P6.291)
Subei, Adnan, Garza, Ivan , Flink, Michael T., Smith, Ryan

Mayo Clinic

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p6.291 Get It

New Etiology for Orthostatic Headache (P1.299)
Smith, Ryan M. , Garza, Ivan , Robertson, Carrie E.

Mayo Clinic

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p1.299 Get It

S841 Increased Risk of Respiratory Syncytial Virus Among Patients With Inflammatory Bowel Disease
Smith, Ryan A. , Kochhar, Gursimran , Desai, Aakash , Hayney, Mary S. , Hashash, Jana G. , Farraye, Francis A. , Caldera, Freddy

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S621-S622

10.14309/01.ajg.0000953004.33437.ac Get It